Anavex Life Sciences Stock Performance
| AVXL Stock | USD 4.12 0.08 1.98% |
On a scale of 0 to 100, Anavex Life holds a performance score of 9. The firm shows a Beta (market volatility) of 1.72, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Anavex Life will likely underperform. Please check Anavex Life's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Anavex Life's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Anavex Life Sciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent basic indicators, Anavex Life disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Anavex Life Relative Risk vs. Return Landscape
If you would invest 308.00 in Anavex Life Sciences on November 23, 2025 and sell it today you would earn a total of 104.00 from holding Anavex Life Sciences or generate 33.77% return on investment over 90 days. Anavex Life Sciences is currently generating 0.6163% in daily expected returns and assumes 5.2928% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Anavex, and 88% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Anavex Life Target Price Odds to finish over Current Price
The tendency of Anavex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.12 | 90 days | 4.12 | about 56.36 |
Based on a normal probability distribution, the odds of Anavex Life to move above the current price in 90 days from now is about 56.36 (This Anavex Life Sciences probability density function shows the probability of Anavex Stock to fall within a particular range of prices over 90 days) .
Anavex Life Price Density |
| Price |
Predictive Modules for Anavex Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Anavex Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anavex Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anavex Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Anavex Life is not an exception. The market had few large corrections towards the Anavex Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Anavex Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Anavex Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.48 | |
β | Beta against Dow Jones | 1.72 | |
σ | Overall volatility | 0.50 | |
Ir | Information ratio | 0.10 |
Anavex Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Anavex Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Anavex Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Anavex Life Sciences is way too risky over 90 days horizon | |
| Anavex Life Sciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (46.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Anavex Life Sciences currently holds about 149.16 M in cash with (39.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91. | |
| Anavex Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from fool.com: Biotech Beat Nvidia in 2025. Can It Do It Again |
Anavex Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Anavex Stock often depends not only on the future outlook of the current and potential Anavex Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anavex Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 85.3 M | |
| Cash And Short Term Investments | 102.6 M |
Anavex Life Fundamentals Growth
Anavex Stock prices reflect investors' perceptions of the future prospects and financial health of Anavex Life, and Anavex Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Anavex Stock performance.
| Return On Equity | -0.34 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 232.45 M | ||||
| Shares Outstanding | 92.67 M | ||||
| Price To Earning | (11.03) X | ||||
| Price To Book | 2.88 X | ||||
| EBITDA | (46.38 M) | ||||
| Cash And Equivalents | 149.16 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 8.95 M | ||||
| Debt To Equity | 0.01 % | ||||
| Book Value Per Share | 1.37 X | ||||
| Cash Flow From Operations | (39.04 M) | ||||
| Earnings Per Share | (0.46) X | ||||
| Total Asset | 103.81 M | ||||
| Retained Earnings | (382.45 M) | ||||
| Current Asset | 9.45 M | ||||
| Current Liabilities | 3.19 M | ||||
About Anavex Life Performance
By examining Anavex Life's fundamental ratios, stakeholders can obtain critical insights into Anavex Life's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Anavex Life is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system diseases. The company was incorporated in 2004 and is headquartered in New York, New York. Anavex Lf operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.Things to note about Anavex Life Sciences performance evaluation
Checking the ongoing alerts about Anavex Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Anavex Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Anavex Life Sciences is way too risky over 90 days horizon | |
| Anavex Life Sciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (46.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Anavex Life Sciences currently holds about 149.16 M in cash with (39.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91. | |
| Anavex Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from fool.com: Biotech Beat Nvidia in 2025. Can It Do It Again |
- Analyzing Anavex Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Anavex Life's stock is overvalued or undervalued compared to its peers.
- Examining Anavex Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Anavex Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Anavex Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Anavex Life's stock. These opinions can provide insight into Anavex Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Anavex Life assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Anavex Life's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Anavex Life represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Anavex Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.